相似文献
1
O-GlcNAc signaling in cancer metabolism and epigenetics.
Cancer Lett. 2015 Jan 28;356(2 Pt A):244-50. doi: 10.1016/j.canlet.2014.04.014. Epub 2014 Apr 24.
2
The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
Sci STKE. 2005 Nov 29;2005(312):re13. doi: 10.1126/stke.3122005re13.
3
Potential coordination role between O-GlcNAcylation and epigenetics.
Protein Cell. 2017 Oct;8(10):713-723. doi: 10.1007/s13238-017-0416-4. Epub 2017 May 9.
4
The potential role of O-GlcNAc modification in cancer epigenetics.
Cell Mol Biol Lett. 2014 Sep;19(3):438-60. doi: 10.2478/s11658-014-0204-6. Epub 2014 Aug 20.
5
Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Cardiovasc Res. 2022 Jan 7;118(1):212-225. doi: 10.1093/cvr/cvab043.
6
Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
J Biol Chem. 2011 Oct 28;286(43):37483-95. doi: 10.1074/jbc.M111.284885. Epub 2011 Sep 6.
7
Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
Pharmacol Res. 2021 Mar;165:105467. doi: 10.1016/j.phrs.2021.105467. Epub 2021 Jan 27.
8
Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.
Adv Cancer Res. 2015;126:137-66. doi: 10.1016/bs.acr.2014.12.003. Epub 2015 Feb 7.
9
Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
J Biol Chem. 2014 Dec 12;289(50):34457-65. doi: 10.1074/jbc.R114.577718. Epub 2014 Oct 21.
10
Gene expression of O-GlcNAc cycling enzymes in human breast cancers.
Clin Exp Med. 2012 Mar;12(1):61-5. doi: 10.1007/s10238-011-0138-5. Epub 2011 May 13.
引用本文的文献
1
FTO O-GlcNAcylation promotes TRIM21-mediated FTO ubiquitination degradation to sustain the negative feedback control of macrophage inflammation.
Front Immunol. 2025 Jun 26;16:1593243. doi: 10.3389/fimmu.2025.1593243. eCollection 2025.
2
Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism.
Cell Death Differ. 2025 Mar 5. doi: 10.1038/s41418-025-01473-z.
3
Exploring biomarkers and molecular mechanisms of Type 2 diabetes mellitus promotes colorectal cancer progression based on transcriptomics.
Sci Rep. 2025 Feb 3;15(1):4086. doi: 10.1038/s41598-025-88520-4.
4
FUT2 promotes colorectal cancer metastasis by reprogramming fatty acid metabolism via YAP/TAZ signaling and SREBP-1.
Commun Biol. 2024 Oct 10;7(1):1297. doi: 10.1038/s42003-024-06993-x.
5
A protein O-GlcNAc glycosyltransferase regulates the antioxidative response in Yersinia pestis.
Nat Commun. 2024 Aug 16;15(1):7062. doi: 10.1038/s41467-024-50959-w.
6
O-GlcNAcase regulates pluripotency states of human embryonic stem cells.
Stem Cell Reports. 2024 Jul 9;19(7):993-1009. doi: 10.1016/j.stemcr.2024.05.009. Epub 2024 Jun 27.
7
Regulation of Hypoxia Dependent Reprogramming of Cancer Metabolism: Role of HIF-1 and Its Potential Therapeutic Implications in Leukemia.
Asian Pac J Cancer Prev. 2024 Apr 1;25(4):1121-1134. doi: 10.31557/APJCP.2024.25.4.1121.
8
Hexosamine biosynthesis and related pathways, protein N-glycosylation and O-GlcNAcylation: their interconnection and role in plants.
Front Plant Sci. 2024 Mar 6;15:1349064. doi: 10.3389/fpls.2024.1349064. eCollection 2024.
9
Potential therapies targeting nuclear metabolic regulation in cancer.
MedComm (2020). 2023 Nov 29;4(6):e421. doi: 10.1002/mco2.421. eCollection 2023 Dec.
10
O-GlcNAcylation Is Required for the Survival of Cerebellar Purkinje Cells by Inhibiting ROS Generation.
Antioxidants (Basel). 2023 Mar 26;12(4):806. doi: 10.3390/antiox12040806.
本文引用的文献
1
Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked β-N-acetylglucosamine transferase (OGT).
J Biol Chem. 2014 Feb 28;289(9):5986-96. doi: 10.1074/jbc.M113.524140. Epub 2014 Jan 6.
2
HCF-1 is cleaved in the active site of O-GlcNAc transferase.
Science. 2013 Dec 6;342(6163):1235-9. doi: 10.1126/science.1243990.
3
A new world of Polycombs: unexpected partnerships and emerging functions.
Nat Rev Genet. 2013 Dec;14(12):853-64. doi: 10.1038/nrg3603. Epub 2013 Nov 12.
4
O-GlcNAcylation of cofilin promotes breast cancer cell invasion.
J Biol Chem. 2013 Dec 20;288(51):36418-25. doi: 10.1074/jbc.M113.495713. Epub 2013 Nov 8.
5
Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.
J Biol Chem. 2013 Nov 22;288(47):33927-33938. doi: 10.1074/jbc.M113.500983. Epub 2013 Oct 15.
6
Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Oncol Rep. 2013 Dec;30(6):2929-36. doi: 10.3892/or.2013.2794. Epub 2013 Oct 11.
7
Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation.
Nature. 2013 Oct 17;502(7471):372-6. doi: 10.1038/nature12537. Epub 2013 Sep 29.
8
O-GlcNAcylation: A New Cancer Hallmark?
Front Endocrinol (Lausanne). 2013 Aug 12;4:99. doi: 10.3389/fendo.2013.00099. eCollection 2013.
9
Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.
Mol Cancer Ther. 2013 Oct;12(10):2067-77. doi: 10.1158/1535-7163.MCT-13-0314. Epub 2013 Aug 19.
10
O-GlcNAc in cancer biology.
Amino Acids. 2013 Oct;45(4):719-33. doi: 10.1007/s00726-013-1543-8. Epub 2013 Jul 9.
Zotero 插件